The result of a study published
in the Archives of Internal Medicine, one
of the JAMA/Archives
journals finds that statin use in postmenopausal women significantly increases
the risk of developing diabetes. In spite of this damning evidence, researchers
do not recommend that American Diabetes Association guidelines for primary and
secondary prevention should be changed. Statins account for hundreds of
billions in pharmaceutical sales each year, and there is scant evidence they do
anything to promote cardiovascular or overall health.
In addition to contributing to
muscle wasting and metabolic imbalance, this research provides yet another
reason to avoid this energy-sapping class of drug. Health-conscious individuals
avoid pharmaceuticals at all cost, and there is now compelling research to
suggest that everyone should seriously question taking statins to prevent an
unnecessary risk of diabetes.
Statins Shown to Dramatically Increase Diabetes Incidence in
Postmenopausal Women
Dr. Annie L. Culver and her team
from the Rochester Methodist Hospital, Mayo Clinic in Minnesota analyzed data
from the national, multiyear Women's Health Initiative (WHI) to garner results
for this study. Researchers analyzed data to include 153,840 women without
diabetes with an average age of 63 years. Statin
use was assessed at enrollment and again in year three. At the outset, 7
percent of the women reported taking a statin medication.
The scientists found 10,242 new
cases of diabetes and determined that statin use was positively associated with
an increased risk of diabetes. The association remained after adjusting for other
potential variables, including age, race or ethnicity and body mass index, and
was observed for all types of statins. Dr. Culver noted “The results of this study imply that statin
use conveys an increased risk of new-onset DM (diabetes mellitus) in
postmenopausal woman.”
Statins Cause Low Cellular Energy Damaging Metabolism That Leads to
Type II Diabetes
A deeper analysis of the data
found that diabetes incidence increased in this cohort of postmenopausal women
by 71%. Amazingly, the result of this study has received no media attention.
The scant coverage that has been published fully discounts the additional risk
burden and continues to tout the ‘heart-healthy’ benefits of statin use. The
real truth is that statins are anti-energy by core means of operation. Any time
you reduce the energy function of a cell you reduce the ability of that cell to
burn calories as fuel.
Low cellular energy
function creates metabolic inefficiency and insulin resistance, with increased
fatigue and eventual type 2 diabetes. Statins are a recipe for metabolic
disaster, yet millions of unsuspecting women and men continue to blindly
swallow these ‘magic pills’ in the belief that they can continue to consume a
poor diet and have full immunity against heart disease and a host of other
chronic illnesses ascribed to statin use. The evidence is in and it couldn’t be
clearer for those individuals with the will to listen and the desire to
dramatically lower their risk of becoming diabetic.